{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:20:10Z","timestamp":1761718810056,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejpb.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:51:50Z","timestamp":1562158310000},"page":"353-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A unified in vitro test system for the assessment of tight junction modulators"],"prefix":"10.1016","volume":"142","author":[{"given":"Daniel","family":"Saaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"MALDI-HTS beyond 100,000 samples per day in Drug Discovery","key":"10.1016\/j.ejpb.2019.07.004_b0005"},{"key":"10.1016\/j.ejpb.2019.07.004_b0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"The AAPS J."},{"key":"10.1016\/j.ejpb.2019.07.004_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx J. Am. Soc. Exp. NeuroTherapeutics"},{"year":"1984","series-title":"Pharmacology of the Eye. Ocular Pharmacokinetics","author":"Sears","key":"10.1016\/j.ejpb.2019.07.004_b0020"},{"key":"10.1016\/j.ejpb.2019.07.004_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2016.08.007","article-title":"The role of tight junctions in skin barrier function and dermal absorption","volume":"242","author":"Basler","year":"2016","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2019.07.004_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2019.07.004_b0035","doi-asserted-by":"crossref","first-page":"a002584","DOI":"10.1101\/cshperspect.a002584","article-title":"Physiology and function of the tight junction","volume":"1","author":"Anderson","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1083\/jcb.47.1.49","article-title":"An interpretation of liver cell membrane and junction structure based on observation of freeze-fracture replicas of both sides of the fracture","volume":"47","author":"Chalcroft","year":"1970","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0045","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1083\/jcb.123.6.1777","article-title":"Occludin: a novel integral membrane protein localizing at tight junctions","volume":"123","author":"Furuse","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0050","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","article-title":"Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin","volume":"141","author":"Furuse","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0055","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1083\/jcb.200510043","article-title":"Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells","volume":"171","author":"Ikenouchi","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.142.1.117","article-title":"Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration","volume":"142","author":"Mart\u00ecn-Padura","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0065","doi-asserted-by":"crossref","first-page":"29745","DOI":"10.1074\/jbc.273.45.29745","article-title":"The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton","volume":"273","author":"Fanning","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2019.07.004_b0070","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1083\/jcb.147.6.1351","article-title":"Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins","volume":"147","author":"Itoh","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0075","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.1074\/jbc.M905251199","article-title":"Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin","volume":"275","author":"Bazzoni","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2019.07.004_b0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1152\/ajpcell.1987.253.6.C854","article-title":"Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction","volume":"253","author":"Madara","year":"1987","journal-title":"Am. J. Physiol."},{"year":"2008","series-title":"Molecular Cell Biology","author":"Lodish","key":"10.1016\/j.ejpb.2019.07.004_b0085"},{"key":"10.1016\/j.ejpb.2019.07.004_b0090","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1242\/jcs.02915","article-title":"Turner, Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure","volume":"119","author":"Le Shen","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejpb.2019.07.004_b0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/17460441.2014.892070","article-title":"Recent progress in tight junction modulation for improving bioavailability","volume":"9","author":"Saaber","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"year":"2005","series-title":"Molekulare Zellbiologie","author":"Karp","key":"10.1016\/j.ejpb.2019.07.004_b0100"},{"key":"10.1016\/j.ejpb.2019.07.004_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/gb-2009-10-8-235","article-title":"The claudins","volume":"10","author":"Lal-Nag","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1083\/jcb.58.2.390","article-title":"Fracture faces of zonulae occludentes from \u201ctight\u201d and \u201cleaky\u201d epithelia","volume":"58","author":"Claude","year":"1973","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"G\u00fcnzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejpb.2019.07.004_b0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drudis.2007.11.005","article-title":"Targeting tight junction proteins-significance for drug development","volume":"13","author":"Kondoh","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2019.07.004_b0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICU.0b013e328089f1c8","article-title":"The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review","volume":"18","author":"Yee","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0887-2333(97)00026-X","article-title":"Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents","volume":"11","author":"Narai","year":"1997","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"key":"10.1016\/j.ejpb.2019.07.004_b0135","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/js9504604","article-title":"Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells","volume":"85","author":"Tomita","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.004_b0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)37216-7","article-title":"Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells","volume":"284","author":"Lindmark","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2019.07.004_b0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/ajplung.2001.281.6.L1472","article-title":"Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation","volume":"281","author":"Wang","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00784-002-0157-4","article-title":"Chemical-biological interactions of NaF with three different cell lines and the caries pathogen Streptococcus sobrinus","volume":"6","author":"Dogan","year":"2002","journal-title":"Clin. Oral Invest."},{"key":"10.1016\/j.ejpb.2019.07.004_b0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","article-title":"Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches","volume":"64","author":"Cardoso","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejpb.2019.07.004_b0160","first-page":"121","article-title":"Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer","volume":"365","author":"Gopalakrishnan","year":"2009","journal-title":"Int. J. Pharm. (Int. J. Pharmaceut.)"},{"key":"10.1016\/j.ejpb.2019.07.004_b0165","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1023\/A:1018938722768","article-title":"Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers","volume":"16","author":"Mackic","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.004_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17425247.2.2.281","article-title":"Advances in nasal drug delivery through tight junction technology","volume":"2","author":"Johnson","year":"2005","journal-title":"Expert Opin. Drug Deliv. (Expert Opin. Drug Del.)"},{"key":"10.1016\/j.ejpb.2019.07.004_b0175","unstructured":"K. Cui, S.-C. Chen, M.E. Houston, S.C. Quay, Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compounds, United States Patent 7,244,709 B2, 2005."},{"key":"10.1016\/j.ejpb.2019.07.004_b0180","doi-asserted-by":"crossref","unstructured":"K. Matter, M.S. Balda, Functional analysis of tight junctions, Methods (San Diego, Calif.) 30, 2003, pp. 228\u2013234.","DOI":"10.1016\/S1046-2023(03)00029-X"},{"key":"10.1016\/j.ejpb.2019.07.004_b0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0928-0987(00)00152-4","article-title":"Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug","volume":"12","author":"Gaillard","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.004_b0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2012.06554.x","article-title":"Barriers and more: functions of tight junction proteins in the skin","volume":"1257","author":"Kirschner","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejpb.2019.07.004_b0195","first-page":"231","article-title":"Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator","volume":"69","author":"Song","year":"2008","journal-title":"Eur. J. Pharm. Biopharm. (Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft f\u00fcr Pharmazeutische Verfahrenstechnik e.V)"},{"key":"10.1016\/j.ejpb.2019.07.004_b0200","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3171\/jns.1994.81.5.0752","article-title":"Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors","volume":"81","author":"Inamura","year":"1994","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejpb.2019.07.004_b0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biomaterials.2012.09.051","article-title":"Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells","volume":"34","author":"Krug","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.07.004_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/ajpcell.2001.281.2.C388","article-title":"Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers","volume":"281","author":"Watson","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1242\/jcs.021485","article-title":"The density of small tight junction pores varies among cell types and is increased by expression of claudin-2","volume":"121","author":"Itallie","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejpb.2019.07.004_b0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J. Pharm. Sci."},{"year":"2010","series-title":"Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications","author":"Freshney","key":"10.1016\/j.ejpb.2019.07.004_b0225"},{"key":"10.1016\/j.ejpb.2019.07.004_b0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","article-title":"Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology","volume":"25","author":"Deli","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0235","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"10.1016\/j.ejpb.2019.07.004_b0240","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1016\/j.chroma.2009.09.026","article-title":"Rapid determination of surfactant critical micelle concentrations using pressure-driven flow with capillary electrophoresis instrumentation","volume":"1216","author":"Stanley","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejpb.2019.07.004_b0245","doi-asserted-by":"crossref","unstructured":"Quenching of Fluorescence, in: J.R. Lakowicz (Ed.), Principles of Fluorescence Spectroscopy, Springer US, Boston, MA, 2006, pp. 277\u2013330.","DOI":"10.1007\/978-0-387-46312-4_8"},{"key":"10.1016\/j.ejpb.2019.07.004_b0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.2042-7158.1995.tb06726.x","article-title":"Ophthalmic preservatives as absorption promoters for ocular drug delivery","volume":"47","author":"Sasaki","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.07.004_b0255","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1248\/bpb.23.1524","article-title":"Modification of ocular permeability of peptide drugs by absorption promoters","volume":"23","author":"Sasaki","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2019.07.004_b0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2007.08.017","article-title":"Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea","volume":"348","author":"Majumdar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.004_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.07.004_b0270","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.addr.2011.07.004","article-title":"Spiral progression in the development of absorption enhancers based on the biology of tight junctions","volume":"64","author":"Kondoh","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.07.004_b0275","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2174\/092986707782023640","article-title":"Tight junction modulators: promising candidates for drug delivery","volume":"14","author":"Kondoh","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2019.07.004_b0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Automat."},{"key":"10.1016\/j.ejpb.2019.07.004_b0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/ICO.0b013e3181a3c3e6","article-title":"Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo","volume":"29","author":"Kusano","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2019.07.004_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(01)00261-2","article-title":"Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines","volume":"122","author":"Burgalassi","year":"2001","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejpb.2019.07.004_b0295","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/1061186X.2016.1258703","article-title":"The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells","volume":"25","author":"Ghadiri","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2019.07.004_b0300","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12272-012-0217-5","article-title":"The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker","volume":"35","author":"Song","year":"2012","journal-title":"Arch. Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119301742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119301742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:21Z","timestamp":1760546301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119301742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":60,"alternative-id":["S0939641119301742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A unified in vitro test system for the assessment of tight junction modulators","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}